Most human GBM cell lines are resistant to TRAIL-induced apoptosis despite high expression levels of TRAILR2 (but minimal TRAILR1) expression [379], yet both at substantially higher levels than seen in astrocytes [78, 85]. The gene discussed is TNFSF10; the disease is glioblastoma.